Adult Stem Cell Therapy for Back Pain – Video
By Dr. Matthew Watson
Adult Stem Cell Therapy for Back Pain
A registered nurse describes her experience with an adult stem cell therapy procedure for back pain. More information at medrebels.org.
By: medrebels1
Go here to read the rest:
Adult Stem Cell Therapy for Back Pain - Video
Uncategorized
Comments Off on Adult Stem Cell Therapy for Back Pain – Video |
August 4th, 2013
Advanced Topics – Stem Cell Therapy part 1 – Video
By Sykes24Tracey
Advanced Topics - Stem Cell Therapy part 1
By: Jesse Matteson
Here is the original post:
Advanced Topics - Stem Cell Therapy part 1 - Video
Uncategorized
Comments Off on Advanced Topics – Stem Cell Therapy part 1 – Video |
August 4th, 2013
Can Genetic Engineering Save the Orange, and Vice Versa? – New York Times (blog)
By Dr. Matthew Watson
 New York Times (blog) | Can Genetic Engineering Save the Orange, and Vice Versa? New York Times (blog) Ricke Kress of Southern Gardens Citrus has high hopes for his secret plot of test trees Richard Perry/The New York Times Ricke Kress of Southern Gardens Citrus has high hopes for his secret plot of test trees, some of which are genetically modified. In ... |
Uncategorized
Comments Off on Can Genetic Engineering Save the Orange, and Vice Versa? – New York Times (blog) |
August 4th, 2013
O’Malley Highlights How Biotechnology Benefits The Economy – CBS Local
By Dr. Matthew Watson
O'Malley Highlights How Biotechnology Benefits The Economy CBS Local ANNAPOLIS, Md. (WJZ) — New technologies being developed in the University of Maryland biopark are making a difference to the state's economy. Pat Warren reports on some of the progress. Governor Martin O'Malley credits Maryland's biopark with ... O'Malley to highlight biotechnologyMiamiHerald.com |
Uncategorized
Comments Off on O’Malley Highlights How Biotechnology Benefits The Economy – CBS Local |
August 4th, 2013
Ghanaian Journalists Trained In Biotechnology – Ghana
By Dr. Matthew Watson
Ghanaian Journalists Trained In Biotechnology Ghana The Ghana Journalists Association (GJA), in collaboration with Africa Harvest Foundation International (Africa Harvest), has organised a biosafety workshop for Ghanaian journalists to enable them to report issues on biotechnology more accurately. |
Uncategorized
Comments Off on Ghanaian Journalists Trained In Biotechnology – Ghana |
August 4th, 2013
INEOS Bio’s New Bio Technology Process Creates Fuel And Electricity From … – International Business Times
By Dr. Matthew Watson
 International Business Times | INEOS Bio's New Bio Technology Process Creates Fuel And Electricity From ... International Business Times A bio energy producer in Florida said Wednesday that it produced mass quantities of ethanol from waste and nonfood matter, a development that could have a significant impact on the fuel industry and the environment. |
Uncategorized
Comments Off on INEOS Bio’s New Bio Technology Process Creates Fuel And Electricity From … – International Business Times |
August 4th, 2013
Amid budget cuts, N.C. Biotechnology Center asking workers to voluntarily resign – Triangle Business Journal
By Dr. Matthew Watson
Amid budget cuts, N.C. Biotechnology Center asking workers to voluntarily resign Triangle Business Journal The North Carolina Biotechnology Center has started a “voluntary separation program” in attempts to avoid layoffs. The move, targeting the organization's veteran employees, is in response to the $4.6 million cut in funding for the center that was ... |
Uncategorized
Comments Off on Amid budget cuts, N.C. Biotechnology Center asking workers to voluntarily resign – Triangle Business Journal |
August 4th, 2013
UNR hatches biotechnology startup DxDiscovery – Sparks Today
By Dr. Matthew Watson
UNR hatches biotechnology startup DxDiscovery Sparks Today The startup, a biotechnology company created by UNR researchers, needed a numbers guy. It would be Maine's introduction to the fast-paced and crazy world of startups. Only in a startup, for example, would a person find himself switching from an ... |
Uncategorized
Comments Off on UNR hatches biotechnology startup DxDiscovery – Sparks Today |
August 4th, 2013
Pay-for-Eggs Legislation: A Comment on Risk
By Dr. Matthew Watson
the eggs legislation item today has responded to a comment filed
by two persons opposed to the measure that would remove the ban in
California on paying women for their eggs for scientific research.
executive director of the Genetic Literacy Project.
“Diane and Nancy, I'm shocked that
you are either unaware or do not acknowledge that there are studies
of oocyte retrieval surgeries that show very persuasively that the
potential harm from this procedure is manageable. While you refer to 'stories' of women being harmed--that's called anecdotal
evidence and is the antithesis of science--you ignore the established
research in this area, which makes it clear that you are reacting
hysterically rather than responding to empirical evidence. I would
suggest that you read the National Academies Press workshop report:
Assessing the Medical Risks of Human Oocyte Donation for Stem Cell
Research (http://www.nap.edu/catalog.php?record_id=11832).
It cites numerous studies, including a German study that examined the
outcome of approximately 380,000 oocyte retrieval surgeries during
2000-2004. For the procedures for which there was information, the
rate of complications was very low: only 0.002 percent—2 in every
100,000—had complications that required surgery to correct.
“Studies have also examined the
potential risks of retrieval for a woman's future fertility.
“According to one large study, the
rate of infection after oocyte retrieval was about 1 in every 200 IVF
cycles, and surgery is needed to treat pelvic abscesses in less than
1 in 1,000 IVF cycles.
“About five hundred egg donations
take place in Canada each year, according to the Canadian Fertility
and Andrology Society.The CFAS told me that, between 2001 and 2010,
only two donors in Canada, out of a total of 4,177 donations,
suffered from “severe” OHSS, which usually involves
hospitalization. Fourteen others had “moderate” OHSS. These
numbers are collected in a database called the Canadian Assisted
Reproductive Technologies Registry.
“So sure, you can find your 'stories' but they do not represent a scientific review of the available
data--you are trying to legislate based on fear. That's not science;
that's the dark ages, and it's exactly the tactics used by
anti-abortionists (and indeed by organizations like the Center for
Genetics and Society which opposes such beneficial advances as
mitochondrial replacement surgery).
“Furthermore, because women have a
set of two ovaries and two fallopian tubes, they can remain fertile
even if one set is damaged, and there is no evidence that both might
be threatened simultaneously by the side effects of retrieval
surgery.
“Today doctors have had two decades
of experience with the use of hormone treatments to maximize the
number of eggs that can be harvested from a woman, and they have
become quite proficient in the production of oocytes. During that
time they have also worked to improve the safety of the procedure and
decrease the potential risks. Despite these improvements some risk
will remain, because hormones have a powerful effect on the body—they
could not increase egg production so dramatically if this were not
true—and anything with a powerful effect on the body has the
potential for harmful side effects as well.
“Egg donations are done for a reason.
There are risks and benefits. For you to exaggerate the risks based
on 'stories' and ignore the evidence is unconscionable.
It's exactly what anti-abortion groups do and what opponents of
genetically modified foods do--you promote fear around manageable (or
in the case of GMOs, negligible) risk.
“Your call for 'further studies' is the age old technique of reactionaries trying to control other
people and impose their values on other people. You know darned well,
because of your fundamental ideological opposition to this procedure,
no study results could ever meet your standard of acceptability.
“You are trying to control other
women's bodies, claiming you have superior knowledge and
wisdom--those are pro-life talking points. Your views, and that of
the organizations that you represent, are illiberal.”
Source:Comment re Pay-for-Eggs Item and Forbes Article
By Dr. Matthew Watson
Sacramento Bee has filed a comment in connection with an item today on the California Stem Cell Report. The item dealt with the California pay-for-eggs bill, which was also the subject of an op-ed piece in The Sacramento Bee as well as an article yesterday on the Forbes
magazine website that discussed the op-ed piece critically.
today.
Nancy Scheper-Hughes, a professor of anthropology at UC Berkeley and
director of Organs Watch. Diane Tober, associate executive director of the Center for
Genetics and Society of Berkeley, was the other author.
“Dr. Diane Tober and Prof. Nancy
Scheper-Hughes are 'pro choice' social scientists who are
concerned about the absence of any evidence-based medicine on the
long term effects of hyper-stimulation for oocyte (egg) production in
young women research subjects. We are not concerned about abortion,
right to life, or obstructing needed and valuable research on
stem cells. We are concerned about the safety for potential research
subjects who are being actively recruited to participate in
invasive medical procedures without any medical research
studies on the possible risks and consequences of egg multiplication
and extraction. We are on record that we fully support stem
cell research but not at the expense of unprotected egg donors.”
Source:Stem Cell Therapy
Comments Off on Comment re Pay-for-Eggs Item and Forbes Article |
August 4th, 2013
Pay-for-Eggs Legislation Now Before California Gov. Jerry Brown
By Dr. Matthew Watson
officially on Gov. Jerry Brown's desk, awaiting his signature or
veto.
Susan Bonilla, D-Concord, was sent to the governor at 4:45 p.m. PDT
yesterday. On July 1, it easily won legislative approval and
has been held in legislative processing since then. The governor has
12 days to act on the measure or it becomes law without his
signature.
ban on payment to women for their eggs for scientific purposes.
Currently women who provide their eggs for fertility purposes can be
compensated. Fees run as high as $50,000 in some cases, depending on
the characteristics of the woman providing the eggs, but generally
are in the $10,000 range or less. The bill does not affect the ban on
the use of funds from the California stem cell agency to compensate
egg providers.
billion-a-year fertility industry, which is backing it on motherhood
and sexual equity grounds. Supporters say women should receive
payment for their eggs just as men are paid for their sperm. They
also argue that more eggs are needed for research into fertility
problems. In the stem cell field, scientists have also said it is
nearly impossible to find women who will provide eggs unless they are
paid.
stimulating production of eggs can be risky or dangerous. They say
that the longterm effects of the process have not been studied well.
They also argue that it will lead to exploitation of low income and
minority women to produce eggs that then can become a profitable
commodity for the largely unregulated fertility industry. (For more
informationon on the bill, see here, here and here.)
Bee, opponents cited the late philosopher Ivan Illich, who was much admired by Jerry Brown, who considered him a friend. Illich was quoted as warning "against the processes of medical
industries which 'create new needs and control their satisfaction and
turn human beings and their creativity into objects.'"
committed to signing the bill.
yesterday in an article on the Forbes magazine website by Jon Entine.
He wrote,
“Should activist groups, working
through legislators, exercise their control over women’s
reproduction? Do we really 'own' our own bodies? Or does that tenet
only hold when nanny groups say it’s okay?”
The egg legislation may have implications for
regulation of stem cell research by the state Department of Public
Health(again not involving the California stem cell agency). Last
month the California Stem Cell Report asked Hank Greely, a Stanford
law professor and chair of the state department's Human Stem Cell Research Advisory Committee, about the measure. He replied,
“Well, if (when?) AB 926 is signed, I
think our committee should meet to consider what recommendations we
would make to the (the department) as a result of the bill. Those
recommendations could lead, if the committee and the department
agree, to a revision of the state guidelines. As a matter of
law, a statute, particularly a subsequent statute, trumps a guideline
where they are in conflict, but basically I expect we'll see what the
committee thinks and what the department decides. I don't wish
to guess at the results of either process.”
publicly during the debate on the legislation deals with whether human eggs provided with compensation would be subject to state sales tax at any stage in the process. A check of the tax code, however, makes it
clear that eggs are tax free. The code states that “any human body
parts held in a bank for medical purposes, shall be exempt from
taxation for any purpose." The definition of “bank”
includes research facilities, and "medical purposes" includes research.
Source:Stem Cell Therapy
Comments Off on Pay-for-Eggs Legislation Now Before California Gov. Jerry Brown |
August 4th, 2013
Skimpy Coverage of Alpha Clinic Concept Approval
By Dr. Matthew Watson
California stem cell agency's ambitious, $70 million Alpha clinic
plan has been quite light but does include one article in the Los
Angeles Times, the state's largest circulation newspaper.
week by the agency's board with RFAs scheduled to be posted in
October. The agency is seeking to build a basis for a robust stem
cell clinic business in California that would have an international
reach and give the state dominance in the industry.
week quoted CIRM President Alan Trounson as saying in 2010 about
agency's goals.
“If we went 10 years and had no
clinical treatments, it would be a failure. We need to demonstrate
that we are starting a whole new medical revolution.”
voters in 2004 and funded with $3 billion in borrowed money. It will
run out of funds for new grants in 2017.
the plan this week in a story that said,
“The opportunity to run trails under
the well-funded CIRM could be a boon for CROs (contract research
organizations)....But the difficulties of handling the stem cells and
gathering enough patients to enroll in a trial may prove daunting for whatever
company tries to conduct the trials.”
Kevin McCormack as saying,
“No one has reached out to us yet
because the specific details of what we are looking for in the
clinics have not yet been decided.”
Alpha clinic plan was GenNews.
Source:Stem Cell Therapy
Comments Off on Skimpy Coverage of Alpha Clinic Concept Approval |
August 4th, 2013
California Stem Cell Agency Looking for New Home in Two Years
By Dr. Matthew Watson
 |
| The California stem cell agency is located south of Market Street in San Francisco, close to the San Francisco Giants ballpark(upper right). Since the agency has been there, the area has grown from seedy to gentrified. |
San Francisco involving the $3 billion California stem cell agency.
science efforts but everything to do with where it is located and its
overhead expenses. The agency will be forced out of its free office
space – 20,000 square feet – in two years. The free space was
provided under an $18 million recruitment package and is worth at
least $1 million a year, according to the agency's auditors.
office-space market is sizzling hot. Google, Yahoo, Microsoft and
other technology firms are scrambling for space in
Baghdad-by-the-Bay, as the city is sometimes known. According to a story this morning by James Temple in the San Francisco Chronicle,
the firms are looking for a total of about 800,000 square feet and
are prepared to pay well for it.
Yahoo would cost about $48 per square foot for a 10-year lease. If
CIRM paid at that rate, it would have nearly $1 million in additional
costs annually. However, leasing rates are expected to rise substantially in the next year or so. Also involved in a move would
be the cost of parking, which could run about $360,000 a year.
examining its options for new offices, including some sort of special
deal with the City of San Francisco.
chairman of the state Democratic Party and co-vice chairman of CIRM,
briefed agency directors on the matter at its meeting in May. He
said,
“I met with the mayor of San
Francisco(Ed Lee), who's a dear friend, and he encouraged us to be
aware that he's very committed to helping us find some space in San
Francisco. Whether it means tax credits or incentives to a potential
landlord, we still have to work that out. Obviously we still have to
work out what the space will be. But the fact that the mayor has
indicated very explicitly that he wants to keep us in San Francisco,
I think it will bode well for us down the road.“The current owner of the property
(Stockbridge Capital Partners) has not been happy that for ten years
they've had to supply free rent to us. And what they didn't
anticipate was having to provide for over $755,000 in operating
costs, which they thought some donors would take are of. Those donors
-- some of whom passed away and others who chose to give money to
other institutions, UC San Francisco, in particular, to the stem cell
lab, which was very much appreciated, I know, by UCSF – but at
the end of the day, there's no room for negotiations with this
current owner.”
Torres whether future rent would also be free. Torres, who is also
president of San Francisco's Public Utilities Commission, replied,
“I would not work on that assumption.
I would work on the assumption somewhere between a dollar and more,
again, dependent upon what kind of tax incentives the City of San
Francisco would provide. We're very fortunate that my son(Joaquin
Torres) is the deputy mayor for economic development, so we also have
him working on this as well.”
“I'll ask more questions offline.”
Source:Stem Cell Therapy
Comments Off on California Stem Cell Agency Looking for New Home in Two Years |
August 4th, 2013
Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talks about Stem Cell Therapy Treatments – Video
By NEVAGiles23
Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talks about Stem Cell Therapy Treatments
Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talks about Stem Cell Therapy Treatments. Telecast on 23/6/2013 Stem Cell Therapy done at Dr Alok Sharma Ne...
By: Neurogen Brain and Spine Institute
Excerpt from:
Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talks about Stem Cell Therapy Treatments - Video
Uncategorized
Comments Off on Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talks about Stem Cell Therapy Treatments – Video |
July 31st, 2013
Part 2 Stem Cell Therapy – Video
By Dr. Matthew Watson
To Read More: Part 2 Stem Cell Therapy – VideoUncategorized
Comments Off on Part 2 Stem Cell Therapy – Video |
July 31st, 2013
Stem Cell Therapy for Knees – Video
By NEVAGiles23
To Read More: Stem Cell Therapy for Knees – VideoUncategorized
Comments Off on Stem Cell Therapy for Knees – Video |
July 31st, 2013
Stem Cell Therapy – Amazing Breakthrough in Skin wrinkles treatment – Video
By Sykes24Tracey
Stem Cell Therapy - Amazing Breakthrough in Skin wrinkles treatment
Stem Cell Therapy is the newest bio-active topical cream that actually stimulates your own existing skin stem cells to grow smooth, supple, firm new skin. Fo...
By: Buystemcell.com.au
Read this article:
Stem Cell Therapy - Amazing Breakthrough in Skin wrinkles treatment - Video
Uncategorized
Comments Off on Stem Cell Therapy – Amazing Breakthrough in Skin wrinkles treatment – Video |
July 31st, 2013
Discussing: My intro Stem Cell Therapy – Video
By NEVAGiles23
Discussing: My intro Stem Cell Therapy
This video explains my intro into the World of MS.
By: Tiffany Vinson
See the rest here:
Discussing: My intro Stem Cell Therapy - Video
Uncategorized
Comments Off on Discussing: My intro Stem Cell Therapy – Video |
July 29th, 2013
BrainStorm's NurOwn Cell Therapy Receives Orphan Drug Designation in the European Union for ALS
By Sykes24Tracey
NEW YORK, NY and PETAH TIKVA, ISRAEL--(Marketwired - Jul 29, 2013) - BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that the European Commission has granted Orphan Drug Designation for NurOwn, the Company's stem cell therapy consisting of autologous bone marrow-derived mesenchymal stromal cells secreting neurotrophic factors, for the treatment of Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's Disease.NurOwn received Orphan Drug Designation from the Food and Drug Administration (FDA) in 2011.
Orphan drugs benefit from 10 years market exclusivity in the European Union (EU) after marketing approval. Additional benefits for sponsor companies include reduced fees for various centralized activities including applications for marketing authorization, inspections and protocol assistance, as well as possible eligibility for EU grants and other R&D-supporting initiatives.
BrainStorm is currently conducting a Phase IIa dose-escalating trial with 12 ALS patients at the Hadassah Medical Center in Jerusalem, Israel. The company anticipates launching a Phase II multi-center trial at three leading institutions in the United States towards the end of 2013, pending FDA approval.
About BrainStorm Cell Therapeutics, Inc.BrainStorm Cell Therapeutics Inc. is a biotechnology company engaged in the development of first-of-its-kind adult stem cell therapies derived from autologous bone marrow cells for the treatment of neurodegenerative diseases. The Company holds the rights to develop and commercialize its NurOwn technology through an exclusive, worldwide licensing agreement with Ramot, the technology transfer company of Tel Aviv University. For more information, visit the company's website at http://www.brainstorm-cell.com.
Safe Harbor Statement - Statements in this announcement other than historical data and information constitute "forward-looking statements" and involve risks and uncertainties that could cause BrainStorm Cell Therapeutics Inc.'s actual results to differ materially from those stated or implied by such forward-looking statements. Terms and phrases such as "may", "should", "would", "could", "will", "expect", "likely", "believe", "plan", "estimate", "predict", "potential", and similar terms and phrases are intended to identify these forward-looking statements.The potential risks and uncertainties include, without limitation, risks associated with BrainStorm's limited operating history, history of losses; minimal working capital, dependence on its license to Ramot's technology; ability to adequately protect the technology; dependence on key executives and on its scientific consultants; ability to obtain required regulatory approvals; and other factors detailed in BrainStorm's annual report on Form 10-K and quarterly reports on Form 10-Q available at http://www.sec.gov.These factors should be considered carefully, and readers should not place undue reliance on BrainStorm's forward-looking statements.The forward-looking statements contained in this press release are based on the beliefs, expectations and opinions of management as of the date of this press release. We do not assume any obligation to update forward-looking statements to reflect actual results or assumptions if circumstances or management's beliefs, expectations or opinions should change, unless otherwise required by law. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements.
Read more from the original source:
BrainStorm's NurOwn Cell Therapy Receives Orphan Drug Designation in the European Union for ALS
Uncategorized
Comments Off on BrainStorm's NurOwn Cell Therapy Receives Orphan Drug Designation in the European Union for ALS |
July 29th, 2013
Blue Hills Veterinary Hospital – Stem Cell Therapy Success – Video
By JoanneRUSSELL25
Blue Hills Veterinary Hospital - Stem Cell Therapy Success
Visit http://www.bluehillsvet.co.za for more information.
By: Blue Hills Veterinary Hospital
Continue reading here:
Blue Hills Veterinary Hospital - Stem Cell Therapy Success - Video
Uncategorized
Comments Off on Blue Hills Veterinary Hospital – Stem Cell Therapy Success – Video |
July 28th, 2013